Suppression of mutant p53-driven tumor metastasis by the natural product manglisin A via the PIP5K1A-FAK axis

Abstract Background Metastasis is the leading cause of cancer-associated death. p53 mutants promote metastasis, yet the underlying mechanisms have not been clearly elucidated. Drugs that target mutant p53-driven metastasis are needed. This study aimed to identify low-toxicity small-molecule compounds targeting mutant p53-driven metastasis and elucidate the underlying molecular mechanisms. Methods The migration and invasion abilities of the cells were examined by wound healing and Transwell assays. Two machine learning models, XGBoost with SHAP interpretation and MetaNet, were employed to assess the key drivers of mutant p53-associated metastasis. RNA-seq, immunofluorescence staining (IF), coimmunoprecipitation (co-IP), microscale thermophoresis (MST), and drug affinity responsive target stability (DARTS) were used to elucidate the targets and mechanism of action of manglisin A (MA). Zebrafish and murine xenograft models were used to explore the effects of MA in vivo . Results High-throughput wound-healing-based screening was carried out within a natural product library of 647 compounds, and MA was identified to inhibit mutant p53-driven migration and invasion. RNA-seq analysis revealed the PI3K pathway as a key pathway in mutant p53-associated metastasis, which was further supported by SHAP analysis and data from MetaNet. Mechanistically, MA inhibited EMT and metastasis through the mutant p53-PIP5K1A-FAK/Src pathway. Mutant p53 recruited PIP5K1A to the leading edge of the cell membrane in migratory cells, whereas MA disrupted this interaction, further promoting the degradation of PIP5K1A and mutant p53. Moreover, tumors harboring mutant p53 with high PIP5K1A expression are associated with poor prognosis. MA suppressed mutant p53-driven tumor metastasis in vivo . Conclusion Our study highlights the mutant p53-PIP5K1A complex as a potential therapeutic target for metastasis and MA as a potential lead compound for targeting mutant p53-driven metastasis.

Authors

Institutions

Publication Details

Journal
Cell Communication and Signaling
Published
2026-11-17
DOI
https://doi.org/10.1186/s12964-026-03345-6
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Suppression of mutant p53-driven tumor metastasis by the natural product manglisin A via the PIP5K1A-FAK axis

Xiao Ding, Wang Ancui, 丁佳音, Zhengrui Xiang et al.
Cell Communication and Signaling
Cancer-related Molecular Pathways
article

Suppression of mutant p53-driven tumor metastasis by the natural product manglisin A via the PIP5K1A-FAK axis

Xiao Ding, Wang Ancui, 丁佳音, Zhengrui Xiang, Yuhan Zhao, Erkang Zang, Xiaojiang Hao, Aiying Huang, Yueqin Zhao, Yongcui Wang, Fangjiao Zhou
article en

Abstract

Abstract Background Metastasis is the leading cause of cancer-associated death. p53 mutants promote metastasis, yet the underlying mechanisms have not been clearly elucidated. Drugs that target mutant p53-driven metastasis are needed. This study aimed to identify low-toxicity small-molecule compounds targeting mutant p53-driven metastasis and elucidate the underlying molecular mechanisms. Methods The migration and invasion abilities of the cells were examined by wound healing and Transwell assays. Two machine learning models, XGBoost with SHAP interpretation and MetaNet, were employed to assess the key drivers of mutant p53-associated metastasis. RNA-seq, immunofluorescence staining (IF), coimmunoprecipitation (co-IP), microscale thermophoresis (MST), and drug affinity responsive target stability (DARTS) were used to elucidate the targets and mechanism of action of manglisin A (MA). Zebrafish and murine xenograft models were used to explore the effects of MA in vivo . Results High-throughput wound-healing-based screening was carried out within a natural product library of 647 compounds, and MA was identified to inhibit mutant p53-driven migration and invasion. RNA-seq analysis revealed the PI3K pathway as a key pathway in mutant p53-associated metastasis, which was further supported by SHAP analysis and data from MetaNet. Mechanistically, MA inhibited EMT and metastasis through the mutant p53-PIP5K1A-FAK/Src pathway. Mutant p53 recruited PIP5K1A to the leading edge of the cell membrane in migratory cells, whereas MA disrupted this interaction, further promoting the degradation of PIP5K1A and mutant p53. Moreover, tumors harboring mutant p53 with high PIP5K1A expression are associated with poor prognosis. MA suppressed mutant p53-driven tumor metastasis in vivo . Conclusion Our study highlights the mutant p53-PIP5K1A complex as a potential therapeutic target for metastasis and MA as a potential lead compound for targeting mutant p53-driven metastasis.

Cell Communication and Signaling
Kunming Institute of Botany (CN), Chinese Academy of Sciences (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), University of Chinese Academy of Sciences (CN)
National Natural Science Foundation of China, Chinese Academy of Sciences, Natural Science Foundation of Yunnan Province, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences
Good health and well-being
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon